Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pol Specenier

Showing results (21-30 of 57) with videos related to

Pageof 6
Sort By:
The Journal of Clinical Endocrinology and Metabolism|June 30, 2018
Programmed Cell Death-1 Inhibitor-Induced Type 1 Diabetes MellitusKatrien Clotman, Katleen Janssens, Pol Specenier, et al.
The Oncologist|July 4, 2013
Anti-epidermal growth factor receptor therapy in head and neck squamous cell carcinoma: focus on potential molecular mechanisms of drug resistanceCarolien Boeckx, Marc Baay, An Wouters, et al.
Anti-Cancer Drugs|January 21, 2010
Docetaxel, ifosfamide and cisplatin in solid tumour treatment: a phase I studyPol Specenier, Marika Rasschaert, Jan Van den Brande, et al.
American Journal of Clinical Oncology|October 13, 2010
Weekly docetaxel in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neckPol Specenier, Marika Rasschaert, Philippe Vroman, et al.
Cancer Chemotherapy and Pharmacology|September 10, 2015
A phase I study of volasertib combined with afatinib, in advanced solid tumorsJean-Pascal Machiels, Marc Peeters, Catherine Herremans, et al.
Current Treatment Options in Oncology|March 28, 2015
Incorporating anti-VEGF pathway therapy as a continuum of care in metastatic colorectal cancerKonstantinos Papadimitriou, Christian Rolfo, Elien Dewaele, et al.
European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery|June 6, 2015
Long-term remission of locally recurrent oropharyngeal cancer after docetaxel-based chemotherapy plus cetuximabPetr Szturz, Pol Specenier, Carl Van Laer, et al.
Frontiers in Oncology|July 17, 2020
A Literature Review of the Potential Diagnostic Biomarkers of Head and Neck NeoplasmsHeleen Konings, Sofie Stappers, Margot Geens, et al.
Diagnostic Molecular Pathology : the American Journal of Surgical Pathology, Part B|November 18, 2011
Expression analysis on archival material: comparison of 5 commercially available RNA isolation kits for FFPE materialCarolien Boeckx, An Wouters, Bea Pauwels, et al.
American Journal of Cancer Research|August 14, 2015
Establishment and characterization of cetuximab resistant head and neck squamous cell carcinoma cell lines: focus on the contribution of the AP-1 transcription factorCarolien Boeckx, Lina Blockx, Ken Op de Beeck, et al.
Pageof 6

Showing results (21-30 of 57) with videos related to

Sort By:
Pageof 6
The Journal of Clinical Endocrinology and Metabolism|June 30, 2018
Programmed Cell Death-1 Inhibitor-Induced Type 1 Diabetes MellitusKatrien Clotman, Katleen Janssens, Pol Specenier, et al.
The Oncologist|July 4, 2013
Anti-epidermal growth factor receptor therapy in head and neck squamous cell carcinoma: focus on potential molecular mechanisms of drug resistanceCarolien Boeckx, Marc Baay, An Wouters, et al.
Anti-Cancer Drugs|January 21, 2010
Docetaxel, ifosfamide and cisplatin in solid tumour treatment: a phase I studyPol Specenier, Marika Rasschaert, Jan Van den Brande, et al.
American Journal of Clinical Oncology|October 13, 2010
Weekly docetaxel in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neckPol Specenier, Marika Rasschaert, Philippe Vroman, et al.
Cancer Chemotherapy and Pharmacology|September 10, 2015
A phase I study of volasertib combined with afatinib, in advanced solid tumorsJean-Pascal Machiels, Marc Peeters, Catherine Herremans, et al.
Current Treatment Options in Oncology|March 28, 2015
Incorporating anti-VEGF pathway therapy as a continuum of care in metastatic colorectal cancerKonstantinos Papadimitriou, Christian Rolfo, Elien Dewaele, et al.
European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery|June 6, 2015
Long-term remission of locally recurrent oropharyngeal cancer after docetaxel-based chemotherapy plus cetuximabPetr Szturz, Pol Specenier, Carl Van Laer, et al.
Frontiers in Oncology|July 17, 2020
A Literature Review of the Potential Diagnostic Biomarkers of Head and Neck NeoplasmsHeleen Konings, Sofie Stappers, Margot Geens, et al.
Diagnostic Molecular Pathology : the American Journal of Surgical Pathology, Part B|November 18, 2011
Expression analysis on archival material: comparison of 5 commercially available RNA isolation kits for FFPE materialCarolien Boeckx, An Wouters, Bea Pauwels, et al.
American Journal of Cancer Research|August 14, 2015
Establishment and characterization of cetuximab resistant head and neck squamous cell carcinoma cell lines: focus on the contribution of the AP-1 transcription factorCarolien Boeckx, Lina Blockx, Ken Op de Beeck, et al.
Pageof 6